Control Bionics Limited (ASX: CBL)
Australia
· Delayed Price · Currency is AUD 0.0580
0.00 (0.00%)
Dec 20, 2024, 3:23 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 14.36 million as of December 20, 2024. Its market cap has increased by 77.48% in one year.
Market Cap
14.36M
Enterprise Value
14.26M
Revenue
5.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 14.36M, a decrease of -85.40%. That is a compound annual growth rate of -37.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 14.36M | 115.46% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | 78.33M | -20.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 136.66B |
| ResMed Inc. | 56.22B |
| Pro Medicus Limited | 27.49B |
| Fisher & Paykel Healthcare Corporation Limited | 20.15B |
| Cochlear Limited | 19.27B |
| Sonic Healthcare Limited | 13.41B |
| Telix Pharmaceuticals Limited | 8.61B |
| Ramsay Health Care Limited | 8.36B |